Drug Trial Radar · NCT07706777
Clinical Study of HRS-2129 for Acute Gouty Arthritis
Last checked: Nov 19, 2026Latest source record: Sep 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Aug 19, 2026
Primary completion
Oct 2026
Study completion Nov 2026
Sponsor
- Lead sponsor
- Shandong Suncadia Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 16, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is being conducted to evaluate the safety, and efficacy of HRS-2129 for acute gouty arthritis. To explore the reasonable dosage of HRS-2129 for acute gouty arthritis.
Conditions
- Acute Gouty Arthritis
Interventions
HRS-2129 TabletDrug
HRS-2129 Tablet; high dose
HRS-2129 TabletDrug
HRS-2129 Tablet; low dose
PlaceboDrug
HRS-2129 Tablet Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline inVisual Analogous Scale pain score at 24 hours post first doseTime frame: from ICF signing date to 24 hours after first dose
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
The Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China · Recruiting
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.